Comparative Efficacy of Autologous Blood and Dextrose Prolotherapy in the Management of Temporomandibular Joint Hypermobility: A Rabbit Model Study
- 19 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 24 (6) , 1969-1975
Abstract
Introduction Temporomandibular joint (TMJ) hypermobility affects broad demographic, challenging the efficacy of traditional treatments. The aim of this study is to investigate therapeutic potential of autologous blood injections (ABI) vs dextrose prolotherapy in rabbit model, through detailed histopathological & radiological analyses. Material and Methods After ethical approval from the institutional committee, a hypermobile joint model was established in rabbits through surgery affirmed by MRI. Subsequently, rabbits were randomly divided into two groups i.e. ABI and dextrose solution. In each group, one joint was designated as control, treated with saline. Following surgical induction of TMJ hypermobility, treatments were administered, & outcome was assessed through histological examination for fibrosis grading & CD68 staining for macrophage infiltration. Results The ABI group exhibited a higher fibrosis grade (> 75% in 50% of joints) & stronger CD68 staining, indicating a significant fibrotic response & macrophage infiltration compared to dextrose group. In contrast, control joints displayed no fibrosis grades & negative CD68 staining. Conclusion The study highlights both ABI & dextrose prolotherapy elicit significant fibrotic responses in treating TMJ hypermobility, indicating their therapeutic mechanisms. ABI in particular, triggers more marked inflammatory reaction, underscoring its potential efficacy. Further evaluation is essential to understand its clinical significance and applicability in managing TMJ disorders.Keywords
Funding Information
- UGC grant (No.R/Dev/D/XII Plan/Recurring/Startup grant/II/76845)
This publication has 15 references indexed in Scilit:
- Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: a single-arm study with 1-4 years’ follow upBritish Journal of Oral and Maxillofacial Surgery, 2017
- Treatment of chronic recurrent dislocation of the temporomandibular joint with injection of autologous blood alone, intermaxillary fixation alone, or both together: a prospective, randomised, controlled clinical trialBritish Journal of Oral and Maxillofacial Surgery, 2013
- Histological evaluation of the changes in temporomandibular joint capsule and retrodiscal ligaments following autologous blood injectionJournal of Cranio-Maxillofacial Surgery, 2013
- Histopathologic Evaluation of Autologous Blood Injection to the Temporomandibular JointJournal of Craniofacial Surgery, 2011
- Autologous blood injection as a new treatment modality for chronic recurrent temporomandibular joint dislocationOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2010
- Autologous Blood Injection for the Treatment of Chronic Recurrent Temporomandibular Joint DislocationJournal of Oral and Maxillofacial Surgery, 2009
- Surgical treatment of chronic temporomandibular joint dislocation: A case reportOral and Maxillofacial Surgery, 2008
- Autologous blood injection for treatment of recurrent temporomandibular joint dislocationOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2001
- Blood‐induced joint damage: A canine in vivo studyArthritis & Rheumatism, 1999
- An animal model for studying mechanisms in human temporomandibular joint disc derangementJournal of Oral and Maxillofacial Surgery, 1994